Sun Pharma scouting for innovative therapies to boost India business
Approved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, almost five times more than the narrow time window of 4-5 hours offered by current treatment options like tissue plasminogen activator (TPA) called thrombolytic drugs that dissolve the clots that cause strokes. An ischemic stroke is a medical emergency that occurs when blood supply to part of a brain is blocked or reduced.
Source: indiatimes.com